Drugs that contain Fluoxetine Hydrochloride; Olanzapine
1. Symbyax patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5945416 | LILLY | Method for treating pain |
Mar, 2017
(7 years ago) | |
| US6960577 | LILLY | Combination therapy for treatment of refractory depression |
Nov, 2017
(6 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Indication(I-593) | Mar 19, 2012 |
| M(M-142) | Oct 10, 2017 |
| New Patient Population(NPP) | Jul 26, 2016 |
Market Authorisation Date: 09 April, 2007
Treatment: Symbyax is indicated for the acute treatment of treatment resistant depression in adults
Dosage: CAPSULE;ORAL
How can I launch a generic of SYMBYAX before it's drug patent expiration?
More Information on Dosage
SYMBYAX family patents
